Yamamoto Katsuya, Okamura Atsuo, Kawano Hiroki, Katayama Yoshio, Shimoyama Manabu, Matsui Toshimitsu
Hematology/Oncology, Department of Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Cancer Genet Cytogenet. 2007 Jul 15;176(2):144-9. doi: 10.1016/j.cancergencyto.2007.04.008.
Constitutional trisomy 8 mosaicism (CT8M) has been considered to be the first mutation in multistep carcinogenesis. We describe the case of a 38-year-old woman with a normal phenotype who developed to acute monocytic leukemia with a novel t(8;18)(q13;q21). Chromosome analysis and spectral karyotyping showed 47,XX,+8,t(8;18)(q13;q21)[20]. Fluorescence in situ hybridization (FISH) demonstrated that the breakpoint at 18q21 was centromeric to the MALT1 and BCL2 genes. FISH also revealed that trisomy 8 was detected in buccal mucosa cells, indicating that trisomy 8 was a constitutional abnormality. These results suggest that t(8;18)(q13;q21) had a crucial role in the development of leukemia as the second mutation following CT8M.
体质性8号染色体三体镶嵌现象(CT8M)被认为是多步骤致癌过程中的首个突变。我们描述了一名38岁表型正常的女性病例,她发展为患有新型t(8;18)(q13;q21)的急性单核细胞白血病。染色体分析和光谱核型分析显示为47,XX,+8,t(8;18)(q13;q21)[20]。荧光原位杂交(FISH)表明,18q21处的断点位于MALT1和BCL2基因的着丝粒侧。FISH还显示在颊黏膜细胞中检测到8号染色体三体,表明8号染色体三体是一种体质性异常。这些结果提示,t(8;18)(q13;q21)作为CT8M后的第二个突变,在白血病的发生发展中起关键作用。